Your browser doesn't support javascript.
loading
Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunity.
Hong, Youji; Robbins, Yvette; Yang, Xinping; Mydlarz, Wojciech K; Sowers, Anastasia; Mitchell, James B; Gulley, James L; Schlom, Jeffrey; Gameiro, Sofia R; Sievers, Cem; Allen, Clint T.
Afiliação
  • Hong Y; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, Maryland, USA.
  • Robbins Y; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, Maryland, USA.
  • Yang X; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, Maryland, USA.
  • Mydlarz WK; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Sowers A; Radiation Biology Branch.
  • Mitchell JB; Radiation Biology Branch.
  • Gulley JL; Geniturinary Malignancy Branch, Center for Cancer Research, and.
  • Schlom J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Gameiro SR; Laboratory of Tumor Immunology and Biology, National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Sievers C; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, Maryland, USA.
  • Allen CT; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, Maryland, USA.
JCI Insight ; 7(5)2022 03 08.
Article em En | MEDLINE | ID: mdl-35260537

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma / Interleucina-12 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: JCI Insight Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma / Interleucina-12 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: JCI Insight Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos